SynthesisFrontiers in immunology2026

Efficacy and safety of adding immune checkpoint inhibitors to standard chemotherapy or chemoradiotherapy for advanced or recurrent cervical cancer: a meta-analysis.

Le Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.